462PA phase I open-label, non-randomized study of...

Annals of Oncology 2019 / 10 Vol. 30; Iss. Supplement

462PA phase I open-label, non-randomized study of recombinant super-compound interferon (rSIFN-co) in patients with advanced solid tumours

Seet, A, Macapagal, M C F, Ahmad, A, Li, G, Goh, M L, Ng, M C H, Tan, T, Tan, D S W, Choo, S P, Lim, W T D, Tai, D W M
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz244.024
Date:
October, 2019
File:
PDF, 83 KB
2019
Conversion to is in progress
Conversion to is failed